NCT00716066 2026-02-27
Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases
Fred Hutchinson Cancer Center
Phase 2 Active not recruiting
Clinical Trials
11 trialsNCT05067348 2025-05-01
tMG
Tang-Du Hospital
Phase 2 Recruiting
NCT04728425 2025-04-27
MG_SCIG
University Health Network, Toronto
Phase 2 Completed
NCT06221501 2024-01-24
Perioperative Efgartigimod for Thymoma and Myasthenia Gravis
Shanghai Zhongshan Hospital
Phase 2 Not yet recruiting
NCT05045248 2021-09-16
Efficacy of Apraclonidine Eye Drops in the Treatment of Ptosis Secondary to Myasthenia Gravis
American University of Beirut Medical Center
Phase 2 Completed
NCT02100969 2021-06-02
Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis
University of Kansas Medical Center
Phase 2 Completed
NCT02110706 2020-03-06
BeatMG: Phase II Trial of Rituximab In Myasthenia Gravis
Yale University
Phase 2 Completed
NCT02102594 2019-12-03
TAVAB
Charite University, Berlin, Germany
Phase 2 Terminated
NCT00814138 2016-05-26
Efficacy of Methotrexate in Myasthenia Gravis
University of Kansas Medical Center
Phase 2 Completed
NCT02317224 2014-12-15
3-Hole
Tang-Du Hospital
Phase 2 Unknown
NCT00774462 2012-12-11
FORCE
Assistance Publique - Hôpitaux de Paris
Phase 2 Completed